News
INVO
1.300
+4.84%
0.060
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
Seeking Alpha · 1d ago
SBFM, BPTH and INDO among pre-market losers
On the Move SBFM, BPTH and INDO among pre-market losers. Hepion Pharmaceuticals -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Terronera surpasses 50% construction completion.
Seeking Alpha · 2d ago
Weekly Report: what happened at INVO last week (0415-0419)?
Weekly Report · 2d ago
INVO Bioscience Navigates Lease Assignment and Nasdaq Woes
TipRanks · 4d ago
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers
Seeking Alpha · 5d ago
LI, VERU and MRIN among pre-market losers
Seeking Alpha · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Chromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. Kineta stock moved upwards by 16.62% and Erasca stock rose 13.73%. Nexalin Technology (NASDAQ:NXL) stock fell 18.4% during the day.
Benzinga · 5d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Redwoods Acquisition stock is rocketing more than 84% on details of a shareholder meeting. The biggest pre-market stock movers this morning are shareholder meetings, earnings reports, a dividend and more. Tritium DCFC stock is crashing over 61% after warning of insolvency.
Investorplace · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. Aileron Therapeutics (NASdaq:ALRN) and 23andMe Holding moved upwards. Losers SeaStar Medical Holding and Aptorum Gr stock decreased by 27.0% during the session.
Benzinga · 6d ago
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Las Vegas Sands Corp. Shares dipped 6.8% to $46.81 on Thursday. The company reported better-than-expected first-quarter results. AGBA Group Holding Limited shares jumped 148% after the company announced a merger agreement with Triller. Other stocks moving in the mid-day session included 23andMe Holding Co. And Vertex Pharmaceuticals.
Benzinga · 6d ago
Veru, EyePoint Pharmaceuticals, SINTX Technologies among healthcare movers
Seeking Alpha · 6d ago
INVO, EZGO and WISA among pre-market losers
Seeking Alpha · 6d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. Mustang Bio stock increased by 11.97% and SINTX Techs stock rose 10.32% in the same session. Losers TRACON Pharma and DIH Holding US stock fell by 16.6% and 14.05% respectively.
Benzinga · 6d ago
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
U.S. Stocks traded lower on Wednesday, with the Nasdaq Composite falling more than 100 points. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21. European shares closed higher on Wednesday. In commodity news, oil traded down 3% to $82.78 and gold traded down 0.8%. U.s. Bancorp reported upbeat first-quarter FY24 earnings. Utilities shares rose by 1.5% on Wednesday after the company reported upbeat results.
Benzinga · 6d ago
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
The Travelers Companies, Inc. Shares dipped 8.1% to $205.03 on Wednesday. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. InVO Bioscience shares shot up 256% after the company reported a year-over-year increase in fourth-quarter revenue.
Benzinga · 04/17 17:36
BUZZ-U.S. STOCKS ON THE MOVE-Outset Medical, Interactive Brokers, US energy sector
Wall Street's main indexes fell in choppy trading on Wednesday. The Dow Jones Industrial Average was down 0.05% and the S&P 500 and the Nasdaq Composite were both down. United Airlines Holdings was among the top percentage gainers. Downbeat earnings reports from some industry majors added to the losses.
Reuters · 04/17 17:33
Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge
U.S. Stocks traded lower midway through trading on Wednesday. The Dow Jones index fell around 100 points and the NASDAQ fell 1.16%. Crude oil inventories climbed by 2.735 million barrels in the week ended April 12. Utilities shares rose by 0.7% on Wednesday; information technology shares fell 0.9%. European shares were higher today.
Benzinga · 04/17 16:44
12 Health Care Stocks Moving In Wednesday's Intraday Session
INVO Bioscience stock rose 275.0% to $2.85 during Wednesday's regular session. The company's Q4 earnings report came out yesterday. Vanda Pharma stock moved upwards by 33.33% during the session. Losers include Longeveron (NASDAQ:LGVN) and Dare BiosScience.
Benzinga · 04/17 16:31
Why Invo BioScience Stock Is Soaring Today
INVO BioScience, Inc. Reported its fourth-quarter financial results after the market close Tuesday. Invo Bioscience reported $1.38 million in quarterly sales, representing a 396.15% increase over the same period last year. The company remains on-track with its goal of reaching break-even or profitability in 2024.
Benzinga · 04/17 15:59
BUZZ-U.S. STOCKS ON THE MOVE-Children's Place, Travelers, First Horizon
Wall Street's main indexes rose on Wednesday. The Dow Jones Industrial Average .DJI was up 0.17% at 37,862.55. United Airlines Holdings was among the top percentage gainers. Children's Place, Travelers and First Horizon were among the biggest decliners.
Reuters · 04/17 14:50
More
Webull provides a variety of real-time INVO stock news. You can receive the latest news about Invo Bioscience Inc through multiple platforms. This information may help you make smarter investment decisions.
About INVO
INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.